Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow-to-Debt Ratio
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow-to-Debt Ratio of 0.04x as of March 2026, meaning its operating cash flow of ₩4.53 Billion could theoretically repay 0% of its total liabilities (₩111.51 Billion) in one year. See Jin Yang Pharmaceutical Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jin Yang Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Jin Yang Pharmaceutical Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see 007370 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Jin Yang Pharmaceutical Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for Jin Yang Pharmaceutical Co. Ltd. Check Jin Yang Pharmaceutical Co. Ltd (007370) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | ₩1.46 Billion | ₩107.95 Billion | ▼ -88.6% |
| 2024 | 0.12x | ₩12.79 Billion | ₩107.70 Billion | ▼ -57.8% |
| 2023 | 0.28x | ₩8.53 Billion | ₩30.32 Billion | ▲ +39.3% |
| 2022 | 0.20x | ₩7.45 Billion | ₩36.87 Billion | ▲ +240.2% |
| 2021 | 0.06x | ₩1.97 Billion | ₩33.18 Billion | ▼ -79.3% |
| 2020 | 0.29x | ₩6.24 Billion | ₩21.77 Billion | ▼ -2.1% |
| 2019 | 0.29x | ₩7.21 Billion | ₩24.61 Billion | ▲ +675.1% |
| 2018 | 0.04x | ₩1.06 Billion | ₩28.01 Billion | ▲ +220.5% |
| 2017 | -0.03x | ₩-987.16 Million | ₩31.47 Billion | ▼ -6337.5% |
| 2016 | 0.00x | ₩-13.47 Million | ₩27.64 Billion | ▲ +99.5% |
| 2015 | -0.10x | ₩-2.76 Billion | ₩27.72 Billion | ▲ +50.9% |
| 2014 | -0.20x | ₩-3.08 Billion | ₩15.20 Billion | — |